D. Medical, a medical device company that develops and manufactures insulin pumps, raised $11 million by offering 1.5 million shares at $7, below the range of $10-$12. D. Medical plans to list on the NASDAQ under the symbol DMED. Rodman & Renshaw acted as lead manager on the deal.
